Prospection Snapshot
We aim to improve health outcomes by enabling evidence-based decisions. We use real world data to generate actionable patient-centric insights, to find misdiagnosed or undertreated patients, to publish evidence in collaboration with therapeutic experts and to support business and clinical decision making.
Prospection is a pioneer in health data analytics technology. Combining advanced AI/ML algorithms and real-world data to unearth health journey insights. We provide actionable real-world evidence that enables better outcomes for patients, across Japan, Asia-Pacific, UK, and USA.
Founded out of Sydney’s Cicada Innovations in 2012, Prospection is guided by credentialled experts and innovative leaders within their respective fields. We analyse large health care data sets (script claims, EMR, Registry, Insurance, Commercial Supply Chain), to better understand the healthcare journey. Working with government, researchers and the health and pharmaceutical industry we have delivered evidence across more than 90 therapy programs, including rare and complex diseases such as oncology, immuno-oncology, virology, metabolic conditions, respiratory and cardiovascular disease. Prospection is backed by Ellerston JAADE, Horizons Ventures and Main Sequence Ventures.
Founded out of Sydney’s Cicada Innovations in 2012, Prospection is guided by credentialled experts and innovative leaders within their respective fields. We analyse large health care data sets (script claims, EMR, Registry, Insurance, Commercial Supply Chain), to better understand the healthcare journey. Working with government, researchers and the health and pharmaceutical industry we have delivered evidence across more than 90 therapy programs, including rare and complex diseases such as oncology, immuno-oncology, virology, metabolic conditions, respiratory and cardiovascular disease. Prospection is backed by Ellerston JAADE, Horizons Ventures and Main Sequence Ventures.